PPARG and atherosclerosis: Given the delicate balance between WNT and PPARγ in VC, this could be a double-edged sword, since a high activation of the WNT/β-catenin pathway, as found in atherosclerosis, could reduce PPARγ availability, shifting the balance towards a pathologically high β-catenin concentration.